Register Financial Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,970
Closed -$302K 389
2025
Q4
$302K Buy
+2,970
New +$239K 0.12% 159
2024
Q4
Sell
-2,985
Closed -$203K 297
2024
Q3
$203K Sell
2,985
-250
-8% -$14.1K 0.1% 167
2024
Q2
$137K Buy
3,235
+450
+16% +$24.8K 0.07% 212
2024
Q1
$192K Sell
2,785
-220
-7% -$13.9K 0.1% 170
2023
Q4
$222K Sell
3,005
-2,015
-40% -$132K 0.15% 145
2023
Q3
$342K Sell
5,020
-800
-14% -$67.9K 0.25% 90
2023
Q2
$546K Sell
5,820
-150
-3% -$11.7K 0.39% 70
2023
Q1
$405K Buy
5,970
+580
+11% +$37.3K 0.32% 83
2022
Q4
$267K Buy
+5,390
New +$220K 0.17% 128

Other funds holding EXAS

Register Financial Advisors's EXAS Position: Q1 2026 in Review

Register Financial Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,970 shares — an estimated $302K sold.

Register Financial Advisors first reported a position in EXAS in Q4 2022 and held it in 9 quarters. The position peaked at $546K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Register Financial Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Register Financial Advisors sold 2,970 Exact Sciences shares in Q1 2026, an estimated $302K.
  • Register Financial Advisors first reported a position in Exact Sciences in Q4 2022 and held it in 9 quarters.
  • Register Financial Advisors's Exact Sciences position peaked at $546K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Register Financial Advisors's 13F filing for Q1 2026, filed 15 Apr 2026.